Curi Bio: Summary

Curi Bio

Biotechnology, Drug Development, Preclinical Research, Tissue Engineering

Curi Bio offers innovative workflows and critical human data to enhance R&D decision-making in drug development.

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics to develop new therapeutics. Their platforms provide advanced 3D tissue models and data analytics for drug safety, efficacy, and potency assessments.

3D Engineered Tissue Models; AI/ML-enabled Insights; Integrated Platforms for Drug Development; High-Throughput Video Contractility Analysis Software

Preclinical drug development; Compound profiling and screening; Assay and model development; Research in human disease models

Best-in-class products and technical support; Focus on human-relevant data for predictive accuracy; Integrated platform that spans the entire preclinical drug development process

Curi Bio's strengths lie in its science-first approach, innovative technology, and commitment to providing human-relevant data for drug discovery.

Curi Bio positions itself as a leader in the biotechnology industry, specializing in advanced tissue models and data analytics for drug discovery.

The primary target users include pharmaceutical companies, biotech firms, and research institutions focused on drug development and translational research.

Request a Quote

• 3D Tissue Models

• Drug Discovery

• AI Analytics

• Human Disease Models

Human Data for Next Generation Medicines

Professional, Innovative, Supportive

Curi Bio uniquely combines advanced 3D tissue models with AI-driven analytics, providing a comprehensive solution for preclinical drug development that focuses on human disease models.

Curi Bio is identified as a science-first organization dedicated to improving drug development processes through innovative technology and expert support.

2015-01-01

• Elliot Fisher